Advancements in Using Immuno-oncology Combination Therapies for Breast Cancer

While several treatment options are available to fight hormone- or Her2-driven breast cancers, options are somewhat limited for 

The EMT6 model was derived from a transplanted hyperplastic alveolar metastatic lung nodule in BALB/c mice.⁴   As further data was generated with this model, observations of metastatic foci in the lung visible upon gross necropsy occurred in up to 40% of control mice.  As metastasis is common in

Glioblastoma (GBM) patients are known to have a poor prognosis and tumor progression with high mortality and a median survival of only 12-15 months. Currently, anti-GBM therapy includes a multi-modality method involving radiotherapies and surgical removal of the tumor in combination with chemotherapy.¹

An estimated one in 20 people will develop colon cancer, making it one of the most frequently diagnosed cancers both in men and women. Due to improved screening methods, the overall incidence of colon cancer has declined during the past 20 years.

In this spotlight, we present data from our initial growth and efficacy studies with the E0771 model. The data presented here provides an overview of the E0771 cell line?s response to immuno-oncology agents and radiation therapy to enable design of rational combination studies.

As a result of the engineered T cell binding to the tumor cell, the T cell becomes activated and kills tumor cells in an MHC unrestricted manor.  Mice in preclinical research studies are followed for a number of predefined parameters, evaluating tumor growth and burden to determine the efficacy of the CAR T cells (

Colorectal cancer (CRC) is a major contributor to the whole of cancer as a disease, representing 10% of all cases of cancer; over one million new cases of CRC were observed worldwide in 2018 resulting in over half a million deaths¹.

The American Cancer Society's estimates for melanoma in the United States for 2021 are about 106,110 new melanomas to be diagnosed (about 62,260 in men and 43,850 in women) and about 7,180 people are expected to die of melanoma (about 4,600 men and 2,580 women).

C1498 is a murine AML cell line that arose spontaneously in a C57BL/6 mouse and grows aggressively in syngeneic mice. Our C1498 line has been luciferase- and mCherry-enabled to permit monitoring of whole body tumor growth by bioluminescence imaging (BLI) and quantification of tumor burden in isolated tissues by flow cytometry, respectively.

Skin cancers include carcinomas of all layers of the skin with the most common being basal cell (BCC) and squamous cell carcinomas (SCC).